• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Our Thanks to Reviewers in 2008

Article

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we “pre-test” article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we “pre-test” article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

And it is why all articles we publish must survive peer review not only by the distinguished leaders in primary care medicine who make up our editorial board (identified on page 999) but also by several specialists and by primary care physicians culled from Consultant readers. We ask reviewers to consider whether the discussion is accurate, balanced, complete, and timely; the drug regimens are reasonable; controversies are fairly outlined; the clinical advice is clear; and the recommended diagnostic and therapeutic measures are widely available in the community.

The questions these reviewers pose help the authors and our staff keep Consultant squarely focused on your educational needs.

In this, the last issue of our 48th year of publication, we want to extend our thanks to the following reviewers who appraised at least one manuscript for us in 2008.

Manal F. Abdelmalek, MD, MPH Robert D. Aby, MD Avanish M. Aggarwal, MD Navin M. Amin, MD Sandra L. Argenio, MD Mohamed G. Atta, MD, MPH Josh Augustine, MD Kirk Barber, MD Eric R. Bates, MD Bruce Becker, MD Michael Becker, MD Somasundaram Bharath, MD Leo P. Bidula, MD Henry R. Black, MD Jerry M. Blaine, MD Robert P. Blereau, MD Philip P. Bonanni, MD John Bond, MD William J. Brady, MD Charles S. Bryan, MD Daniel Carr, MD Michael B. Chancellor, MD Rachmel Cherner, MD John F. Connolly, MD Scott J. Cotler, MD David Effron, MD S. Ather Enam, MD, PhD Richard G. Farmer, MD Jon Fielder, MD Faith T. Fitzgerald, MD Peter Frank, DO
Eli A. Friedman, MD David M. Garzarelli, MD Paul Gleich, MD Caron M. Grin, MD Richard A. Harrigan, MD Andr Hebra, MD Warren A. Heffron, MD Jorge L. Herrera, MD Rudolf Hoehn-Saric, MD Ben Huneycutt, MD Kachi Illoh, MD Jonathan S. Ilowite, MD M. Saleem Ismail, MD Julie Joseph, MD Charles J. Kahi, MD, MSc Deepak M. Kamat, MD, PhD David L. Kaplan, MD Lawrence Kaplan, MD Jeffrey T. Kirchner, DO Stephen J. Lanspa, MD Robert E. Leach, MD Edgar V. Lerma, MD Alexander K. C. Leung, MD Pavel Levy, MD Joseph A. Lieberman III, MD, MPH Joseph K. Lim, MD Jill S. Lindberg, MD Kevin C. Maki, PhD Brian F. Mandell, MD, PhD Richard Y. McConnell, MD Eugene Mochan, PhD, DO
Margaret L. Moline, PhD Majaz Moonis, MD John Mosby, MD Dale P. Murphy, MD Robert R. Myers, PhD David B. Nash, MD, MBA David T. Nash, MD Paul Nathan, MD Linda S. Nield, MD Joseph P. Ornato, MD Richard A. Parker, MD Jacquelinie G. Parthemore, MD Teri Pearlstein, MD Brandon Peters, MD Thomas L. Petty, MD Michael F. Picco, MD, PhD L. Michael Prisant, MD Gary Quick, MD Robert E. Rakel, MD Tangada P. Rao, MD Robert E. Reisman, MD Wayne Reynolds, DO Thomas L. Rodebaugh, MD Jonathan D. Roebuck, MD Malcolm P. Rogers, MD Robert J. Rogers, MD, FACP Susan R. Rose, MD Ted Rosen, MD Andrew Rosenzweig, MD Marti Jill Rothe, MD Ronald N. Rubin, MD
Eric M. Ruderman, MD Gary E. Ruoff, MD Gregory W. Rutecki, MD Samia Sabeen, MD Joseph D. Schmidt, MD Henry Schneiderman, MD, FACP Ronald L. Schwartz, MD Timothy Self, PharmD Edward J. Shahady, MD Leonid Skorin, Jr, DO Clark Smith, MD Andr N. Sofair, MD Steven J. Sondheimer, MD Russell W. Steele, MD Todd P. Stitik, MD Michael B. Strauss, MD Stephen B. Sulavik, MD Arun Swaninath, MD Nicole Touchet, MD Donald G. Vidt, MD Sandeep Vijan, MD Edward M. Weaver, MD, MPH Michael S. Weingarten, MD Michael H. Weisman, MD Herbert White, MD, MPH James T. Willerson, MD Golder N. Wilson, MD, PhD Selma Feldman Witchel, MD Robert J. Wolfson, MD William Yaakob, MD Yusuf Yazici, MD Richard J. Zimmer, DO
Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Duration of Use Guidance Published or Systemic Corticosteroids in Atopic Dermatitis Treatment / image credit Mark Lebwohl, MD Courtesy of Icahn School of Medicine, Mount Sinai

Duration of Use Guidance Published for Systemic Corticosteroids in Atopic Dermatitis Treatment

Grace Halsey
September 12th 2025
Article

The new position paper faults the absence of a clearly defined, evidence-based ceiling on duration of use for the persistent overuse of systemic corticosteroids for AD management.

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Sydney Jennings
September 5th 2025
Podcast

This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.

New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse / image credit FDA logo ©muhammed/stock.adobe.com

New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse

Grace Halsey
September 12th 2025
Article

Opioids are still prescribed to 1 in 5 US adults with chronic pain because effective alternatives are not available; the FDA guidance supports enhanced research paradigms.

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
August 28th 2025
Podcast

This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.

Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data Announced

Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data

Grace Halsey
September 11th 2025
Article

Once-daily blarcamesine was associated with minimal cognitive decline at 48 weeks, with changes comparable to those observed in prodromal aging.

Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents

Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents

Sydney Jennings
September 11th 2025
Article

Merck's CAPVAXIVE could cover approximately 78% of invasive pneumococcal disease cases in youth with chronic health conditions, vs other approved pneumococcal conjugate vaccines.

© 2025 MJH Life Sciences

All rights reserved.